Literature DB >> 21310598

Treatment of glioblastoma multiforme with radiotherapy and concomitant and adjuvant temozolomide: translation of randomised controlled trial evidence into routine clinical practice.

C Herbert, M Williams, H Sawyer, M Greenslade, P Cornes, K Hopkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21310598     DOI： 10.1016/j.clon.2011.01.157

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  3 in total

1.  Change in platelet levels during radiotherapy with concurrent and adjuvant temozolomide for the treatment of glioblastoma: a novel prognostic factor for survival.

Authors:  Matt Williams; Zi Wei Liu; David Woolf; Sarah Hargreaves; Vasiliki Michalarea; Rebecca Menashy; Ishminder Kooner; Elena Wilson
Journal:  J Cancer Res Clin Oncol       Date:  2012-05-27       Impact factor: 4.553

2.  Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study.

Authors:  Whitney B Pope; Xin Joe Qiao; Hyun J Kim; Albert Lai; Phioanh Nghiemphu; Xi Xue; Benjamin M Ellingson; David Schiff; Dawit Aregawi; Soonmee Cha; Vinay K Puduvalli; Jing Wu; Wai-Kwan A Yung; Geoffrey S Young; James Vredenburgh; Dan Barboriak; Lauren E Abrey; Tom Mikkelsen; Rajan Jain; Nina A Paleologos; Patricia Lada; Michael Prados; Jonathan Goldin; Patrick Y Wen; Timothy Cloughesy
Journal:  J Neurooncol       Date:  2012-03-18       Impact factor: 4.130

Review 3.  Pharmacologic therapies for malignant glioma: a guide for clinicians.

Authors:  Riccardo Soffietti; Luca Bertero; Lorenzo Pinessi; Roberta Rudà
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.